BF Biosciences Limited, a biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products in Pakistan, Nepal, Afghanistan, Mauritania, Switzerland, and internationally. The company offers pharmaceutical products for various therapeutic areas, including cardiometabolic disorders, cardiology, diabetes, anti-obesity, hepatology, gastroenterology, chronic kidney diseases, dermatology, antifungal treatments, antibiotics, antivirals, rheumatoid arthritis, nephrology, and oncology. It also provides injectables in vials, ampoules, and pre-filled syringes forms. In addition, the company is involved in the sale of medical devices; and toll manufacturing services for pharmaceutical products to other pharmaceutical companies. It exports its products. The company was incorporated in 2006 and is headquartered in Lahore, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited.
Metrics to compare | BFBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBFBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 30.6x | 19.2x | −0.7x | |
PEG Ratio | −3.32 | 0.17 | 0.00 | |
Price/Book | 2.9x | 2.1x | 2.6x | |
Price / LTM Sales | 2.3x | 1.6x | 3.4x | |
Upside (Analyst Target) | −9.7% | 42.1% | 37.6% | |
Fair Value Upside | Unlock | 14.6% | 4.6% | Unlock |